Single Photon Emission Computed Tomography Market By Product Type (Standalone SPECT Systems, CT Systems, Gamma Cameras, Software & Services, Radiopharmaceuticals), By Radiopharmaceutical Type (Technetium-99m-Based Agents, Thallium-201, Iodine-131, Indium-Based Agents, Novel Targeted Tracers), By Technology (Conventional NaI(Tl) Scintillation Detectors, Solid-State (CZT) Detectors, Single-Head Systems, Multi-Head Systems), By Application (Cardiology, Neurology, Oncology, Bone & Musculoskeletal Imaging, Renal, Pulmonary, and Endocrine Studies, Others), By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research & Academic Institutes, Pharmaceutical & Biotech Companies, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025 – 2035.

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Single Photon Emission Computed Tomography Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. How will rising cardiovascular diseases globally accelerate the adoption of advanced SPECT imaging systems?

3.2.2. Can technological innovations in CZT detectors enhance scan speed and image accuracy significantly?

3.2.3. Will increasing integration of AI and software improve SPECT diagnostic workflow efficiency worldwide?

3.3. Key industry pitfalls & challenges

3.3.1. Does the high cost of SPECT systems limit adoption in small hospitals or clinics?

3.3.2. Could inconsistent radiopharmaceutical supply chains hinder operational reliability and clinical imaging schedules?

3.3.3. Will radiation exposure concerns restrict patient acceptance and regulatory approvals for nuclear imaging?

3.4. Market Opportunities

3.4.1. How can hybrid SPECT/CT systems expand clinical applications across oncology and neurological imaging?

3.4.2. Will emerging markets with improving healthcare infrastructure drive new SPECT system installations?

3.4.3. Can the development of novel targeted radiotracers increase adoption for personalized medicine diagnostics globally?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Single Photon Emission Computed Tomography Market, Product Type Segment Analysis

4.1. Overview of Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Standalone SPECT Systems

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. CT Systems

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Gamma Cameras

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Software & Services

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Radiopharmaceuticals

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Single Photon Emission Computed Tomography Market, Radiopharmaceutical Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Radiopharmaceutical Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Technetium-99 m-Based Agents

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Thallium-201

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Iodine-131

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Indium-Based Agents

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Novel Targeted Tracers

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Single Photon Emission Computed Tomography Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Conventional NaI(Tl) Scintillation Detectors

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Solid-State (CZT) Detectors

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Single-Head Systems

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Multi-Head Systems

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Single Photon Emission Computed Tomography Market, Application Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Application, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Cardiology

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Neurology

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Oncology

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Bone & Musculoskeletal Imaging

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Renal, Pulmonary, and Endocrine Studies

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.7. Others

7.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Single Photon Emission Computed Tomography Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Diagnostic Imaging Centers

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Ambulatory Surgical Centers

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Research & Academic Institutes

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Pharmaceutical & Biotech Companies

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.7. Others

8.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Single Photon Emission Computed Tomography Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Product Type, 2025-2035

9.2.3. North America Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.2.4. North America Market Revenue, By Technology, 2025-2035

9.2.5. North America Market Revenue, By Application, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.4. U.S. Market Revenue, By Application, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Technology, 2025-2035

9.2.8.4. Canada Market Revenue, By Application, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Product Type, 2025-2035

9.3.3. Europe Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.4. Europe Market Revenue, By Technology, 2025-2035

9.3.5. Europe Market Revenue, By Application, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Technology, 2025-2035

9.3.7.4. Germany Market Revenue, By Application, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Product Type, 2025-2035

9.3.8.2. France Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.8.3. France Market Revenue, By Technology, 2025-2035

9.3.8.4. France Market Revenue, By Application, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.4. U.K. Market Revenue, By Application, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Technology, 2025-2035

9.3.10.4. Italy Market Revenue, By Application, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Technology, 2025-2035

9.3.11.4. Spain Market Revenue, By Application, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Product Type, 2025-2035

9.4.7.2. China Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.7.3. China Market Revenue, By Technology, 2025-2035

9.4.7.4. China Market Revenue, By Application, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Technology, 2025-2035

9.4.8.4. Japan Market Revenue, By Application, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Product Type, 2025-2035

9.4.9.2. India Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.9.3. India Market Revenue, By Technology, 2025-2035

9.4.9.4. India Market Revenue, By Application, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Technology, 2025-2035

9.4.10.4. Australia Market Revenue, By Application, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.4. South Korea Market Revenue, By Application, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.4. Singapore Market Revenue, By Application, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Product Type, 2025-2035

9.5.3. Latin America Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.5.4. Latin America Market Revenue, By Technology, 2025-2035

9.5.5. Latin America Market Revenue, By Application, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.4. Brazil Market Revenue, By Application, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.4. Argentina Market Revenue, By Application, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.4. Mexico Market Revenue, By Application, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Radiopharmaceutical Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Application, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Product Type, 2025-2035

9.6.3. MEA Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.6.4. MEA Market Revenue, By Technology, 2025-2035

9.6.5. MEA Market Revenue, By Application, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.4. South Africa Market Revenue, By Application, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Radiopharmaceutical Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Mediso Ltd.

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Siemens Healthineers AG

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. General Electric Company

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Bruker Corporation

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. MiE GmbH

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Digirad Corporation

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Spectrum Dynamics Medical Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Curium Pharma

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Cardinal Health Inc.

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. NTP Radioisotopes SOC Ltd.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Gamma Medica Inc.

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Lantheus Medical Imaging Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Bracco Imaging S.p.A.

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Guerbet S.A.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Neusoft Corporation

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis